Alto Neuroscience Grants New Employee Option to Buy 50,000 Shares

• Alto Neuroscience granted a new employee an option to purchase 50,000 common shares on November 3, 2026.
• The stock option falls under the 2025 Inducement Plan, with a 10-year term.
• The exercise price is $22.70, equal to the stock's closing price on the grant date.
• Vesting spans four years: 25% on the vesting commencement date's first anniversary, with the remainder in equal monthly installments over 36 months.
• Each vesting installment requires the employee's continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alto Neuroscience Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611040657BIZWIRE_USPR_____20261104_BW481125) on November 04, 2026, and is solely responsible for the information contained therein.